本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vera Therapeutics, Inc.

33.97
-0.0800-0.23%
成交量:733.40萬
成交額:2.52億
市值:24.36億
市盈率:-5.76
高:37.13
開:37.00
低:32.84
收:34.05
52周最高:56.05
52周最低:23.05
股本:7,171.39萬
流通股本:5,239.41萬
量比:8.20
換手率:14.00%
股息:- -
股息率:- -
每股收益(TTM):-5.8984
每股收益(LYR):-4.6644
淨資產收益率:-91.75%
總資產收益率:-46.76%
市淨率:5.97
市盈率(LYR):-7.28

資料載入中...

2026/09/15

重要事件披露

Form 8-K - Current report
2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/09

重要事件披露

Form 8-K - Current report
2026/07/07

重要事件披露

Form 8-K - Current report
2026/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

重要事件披露

Form 8-K - Current report
2026/05/27

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans